ELI LILLY & Co — Director's Dealing 2023

Aug 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-08-09

Reporting Person: LILLY ENDOWMENT INC (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-09	Common Stock	S	81132	$528.228	Disposed	100742678	Direct
2023-08-09	Common Stock	S	28158	$529.535	Disposed	100714520	Direct
2023-08-09	Common Stock	S	9871	$530.541	Disposed	100704649	Direct
2023-08-09	Common Stock	S	4600	$531.319	Disposed	100700049	Direct
2023-08-09	Common Stock	S	200	$532.18	Disposed	100699849	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.00 to $528.99, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), and (4) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.00 to $529.9868, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $530.00 to $530.98, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $531.00 to $531.84, inclusive.